ebook Munafa Stock Market Course + Intraday & FNO calls  

       

ZYDUSLIFE announcements Zydus Lifesciences Ltd announcements and dividends declared NSE

Zydus Lifesciences Ltd Complete list of announcements declared & dividend announcements by Zydus Lifesciences Ltd ZYDUSLIFE

Zydus Lifesciences Ltd ZYDUSLIFE listed on NSE and deals in

Announcements and dividends declared by Zydus Lifesciences Ltd ZYDUSLIFE

Zydus Lifesciences introduces biosimilar to protect bone health in cancer patients
Zydus Lifesciences has launched Zyrifa, a Denosumab biosimilar, for treating osteoporosis and preventing skeletal complications in cancer patients. Priced at Rs 12,495, the drug aims to improve access and affordability for patients with bone metastases fro
Announcement as on 10 December 2025

Company Announcement
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 04, 2025, titled "Zydus receives EIR for the injectable facility located at Jarod".
Announcement as on 04 December 2025

Zydus Lifesciences shares in focus after US FDA nods for diabetes and blood pressure drugs
Zydus Lifesciences is set to be in focus after it received tentative approval from the United States Food and Drug Administration for Empagliflozin and Linagliptin combination tablets for type 2 diabetes, alongside final approval for a blood pressure treat
Announcement as on 28 November 2025

Company Announcement
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 27, 2025, titled "Zydus receives tentative approval from USFDA for Empagliflozin and Linagliptin Tablets, 10 mg/5 mg and 25 mg/5 mg".
Announcement as on 27 November 2025

Company Announcement
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 26, 2025, titled "Zydus and RK Pharma enter into an exclusive licensing and commercialization agreement for a novel 505(b)(2) product of supportive oncology treat
Announcement as on 26 November 2025

Announcements by Zydus Lifesciences Ltd first page | Next page | Prev page |

ZYDUSLIFE Zydus Lifesciences Ltd current price & indicator signals

Moving Averages for Zydus Lifesciences Ltd

  • 5Day Average: 883.47
  • 12Day Average: 896.78
  • 20Day Average: 904.08
  • 50Day Average: 898.68
  • 100Day Average: 913.85
  • 150Day Average: 944.35
  • 200Day Average: 951.45

ZYDUSLIFE Indicators & signals

Indicator MACD (12,26,9)

893.89, 899.35, -3.32
Indicator MACD is in negative zone

Indicator ADX (14)

7.4, 21.39, 24.81
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 51
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of ZYDUSLIFE Zydus Lifesciences Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
25 Wed Mar 2026 903.70 886.50 to 914.00 1.95% 1.01 times
24 Tue Mar 2026 886.40 865.10 to 888.90 3% 0.76 times
23 Mon Mar 2026 860.60 858.00 to 899.00 -3.36% 1.17 times
20 Fri Mar 2026 890.50 880.20 to 896.00 1.64% 0.75 times
19 Thu Mar 2026 876.15 874.00 to 894.80 -2.61% 0.65 times
18 Wed Mar 2026 899.60 889.00 to 905.95 1.1% 0.8 times
17 Tue Mar 2026 889.80 887.85 to 902.70 0.33% 1.26 times
16 Mon Mar 2026 886.90 877.10 to 911.90 -2.1% 1.28 times
13 Fri Mar 2026 905.90 901.50 to 924.60 -1.2% 1.52 times
12 Thu Mar 2026 916.90 909.50 to 926.60 -0.53% 0.82 times
11 Wed Mar 2026 921.75 918.00 to 936.15 -0.15% 1 times
10 Tue Mar 2026 923.10 909.00 to 927.00 1.57% 0.97 times

Videos related to: ZYDUSLIFE announcements Zydus Lifesciences Ltd announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

ZYDUSLIFE announcements Zydus Lifesciences Ltd announcements and dividends declared NSE

 

Back to top